magnesium sulfate has been researched along with methyldopa in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (53.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, BA; Goldstein, PJ; London, RS | 1 |
| Brinkman, CR; Woods, JR | 1 |
| Griffis, KR; Martin, JN; Martin, RW; Morrison, JC; Palmer, SM | 1 |
| Cámera, MI; Martinotti, A; Mayorga, LM; Vignolo, CA; Waisman, GD | 1 |
| Barnea, ER; DeCherney, AH; Fakih, H; Naftolin, F; Oelsner, G; Walner, S | 1 |
| Fenakel, K; Katz, Z; Lancet, M; Mogilner, BM; Yemeni, M | 1 |
| Abdella, TN; Anderson, GD; Brooks, TF; Sibai, BM; Spinnato, JA; Taslimi, M | 1 |
| Moodley, J | 1 |
| Grové, D; Hall, DR; Odendaal, HJ; Steyn, DW | 1 |
| Ichikawa, S; Sumino, H | 1 |
| Dennedy, MC; Houlihan, DD; Morrison, JJ; Ravikumar, N | 1 |
| Grové, D; Hall, D; Oettle, C; Roux, A | 1 |
| Arulkumaran, N; Lightstone, L | 1 |
| Chattopadhyay, S; Das, A; Pahari, S | 1 |
| Adepoju, AA; Adetoro, OO; Akadri, AA; Akeju, DO; Bhutta, Z; Dada, OA; Drebit, S; Jaiyesimi, E; Li, L; Magee, LA; Nathan, HL; Nwankpa, CC; Odubena, OO; Payne, B; Sharma, S; Shennan, AH; Sotunsa, J; Soyinka, O; Tu, D; Vidler, M; von Dadelszen, P | 1 |
3 review(s) available for magnesium sulfate and methyldopa
| Article | Year |
|---|---|
The management of hypertension in pregnancy: A review.
Topics: Acute Disease; Adrenergic beta-Antagonists; Anesthesia, Epidural; Anesthesia, Obstetrical; Anticoagulants; Blood Pressure Determination; Clonidine; Delivery, Obstetric; Diazoxide; Diuretics; Female; Fetus; Hospitalization; Humans; Hypertension; Infant, Newborn; Magnesium Sulfate; Methyldopa; Obstetric Labor Complications; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, Third; Reserpine; South Africa; Terminology as Topic; Time Factors; Urate Oxidase | 1980 |
[Hypertension in pregnancy].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bed Rest; Calcium Channel Blockers; Contraindications; Eclampsia; Female; Hemodynamics; Humans; Hypertension; Magnesium Sulfate; Methyldopa; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular | 2004 |
Severe pre-eclampsia and hypertensive crises.
Topics: Administration, Intravenous; Administration, Oral; Antihypertensive Agents; Critical Care; Early Diagnosis; Eclampsia; Female; HELLP Syndrome; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Labetalol; Magnesium Sulfate; Methyldopa; Nifedipine; Nitroglycerin; Pre-Eclampsia; Pregnancy; Risk Assessment; Risk Factors; Severity of Illness Index; Treatment Outcome; United Kingdom | 2013 |
2 trial(s) available for magnesium sulfate and methyldopa
| Article | Year |
|---|---|
Utilization of hydralazine or alpha-methyldopa for the management of early puerperal hypertension.
Topics: Blood Pressure; Fees, Pharmaceutical; Female; Humans; Hydralazine; Hypertension; Magnesium Sulfate; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Random Allocation | 1989 |
Fetomaternal outcome in severe preeclamptic women undergoing emergency cesarean section under either general or spinal anesthesia.
Topics: Adolescent; Adult; Anesthesia, General; Anesthesia, Spinal; Anticonvulsants; Antihypertensive Agents; Apgar Score; Cesarean Section; Female; Fetal Mortality; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Labetalol; Magnesium Sulfate; Maternal Mortality; Methyldopa; Pre-Eclampsia; Pregnancy; Premature Birth; Prospective Studies; Seizures; Severity of Illness Index; Treatment Outcome; Young Adult | 2014 |
10 other study(ies) available for magnesium sulfate and methyldopa
| Article | Year |
|---|---|
Myasthenia gravis and preeclampsia.
Topics: Adult; Female; Furosemide; Humans; Hypertension; Infant, Newborn; Magnesium Sulfate; Male; Methyldopa; Myasthenia Gravis; Pre-Eclampsia; Pregnancy; Pyridostigmine Bromide; Respiratory Insufficiency | 1976 |
The treatment of gestational hypertension.
Topics: Antihypertensive Agents; Chronic Disease; Diazoxide; Female; Humans; Hydralazine; Hypertension; Hypertension, Renal; Kidney Diseases; Magnesium Sulfate; Methyldopa; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Propranolol; Secologanin Tryptamine Alkaloids; Thiazines | 1975 |
Magnesium plus nifedipine: potentiation of hypotensive effect in preeclampsia?
Topics: Adult; Drug Synergism; Female; Humans; Hypertension; Magnesium Sulfate; Methyldopa; Nifedipine; Pre-Eclampsia; Pregnancy | 1988 |
Effect of antihypertensive drugs on catechol-O-methyltransferase and monoamine oxidase activity in human term placental explants.
Topics: Antihypertensive Agents; Catechol O-Methyltransferase; Dose-Response Relationship, Drug; Female; Humans; Hydralazine; In Vitro Techniques; Magnesium Sulfate; Methyldopa; Monoamine Oxidase; Placenta; Pregnancy; Propranolol; Time Factors; Verapamil | 1986 |
[Conservative management of severe pre-eclampsia at less than 36 weeks gestation].
Topics: Female; Fetal Monitoring; Gestational Age; Humans; Infant Mortality; Infant, Newborn; Magnesium Sulfate; Methyldopa; Monitoring, Physiologic; Pre-Eclampsia; Pregnancy | 1986 |
Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester.
Topics: Administration, Oral; Antihypertensive Agents; Bed Rest; Birth Weight; Delivery, Obstetric; Diuretics; Female; Fetal Death; Gestational Age; Humans; Hydralazine; Infant, Newborn; Magnesium Sulfate; Methyldopa; Outcome and Process Assessment, Health Care; Phenobarbital; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, Second; Pregnancy, Prolonged; Retrospective Studies | 1985 |
Expectant management of early onset, severe pre-eclampsia: maternal outcome.
Topics: Adolescent; Adult; Antihypertensive Agents; Calcium Channel Blockers; Dihydralazine; Female; Fetal Distress; Humans; Magnesium Sulfate; Methyldopa; Monitoring, Physiologic; Nifedipine; Prazosin; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Prospective Studies | 2000 |
Anti-hypertensive therapy and the feto-placental circulation: effects on umbilical artery resistance.
Topics: Adult; Antihypertensive Agents; Dose-Response Relationship, Drug; Female; Fetus; Humans; Hydralazine; Labetalol; Magnesium Sulfate; Methyldopa; Nifedipine; Placenta; Pre-Eclampsia; Pregnancy; Regional Blood Flow; Umbilical Arteries; Vascular Resistance | 2004 |
Early onset severe pre-eclampsia: expectant management at a secondary hospital in close association with a tertiary institution.
Topics: Adolescent; Adult; Anticonvulsants; Antihypertensive Agents; Betamethasone; Female; Glucocorticoids; Hospitalization; Humans; Infant Mortality; Infant, Newborn; Magnesium Sulfate; Methyldopa; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prospective Studies; Referral and Consultation; South Africa | 2005 |
The ability and safety of community-based health workers to safely initiate lifesaving therapies for pre-eclampsia in Ogun State, Nigeria: An analysis of 260 community treatments with MgSO
Topics: Adolescent; Adult; Antihypertensive Agents; Benchmarking; Clinical Competence; Community Health Services; Female; Humans; Magnesium Sulfate; Methyldopa; Middle Aged; Nigeria; Pre-Eclampsia; Pregnancy; Young Adult | 2021 |